[go: up one dir, main page]

MX2014004860A - Biomarcadores de cancer de pulmon y usos de los mismos. - Google Patents

Biomarcadores de cancer de pulmon y usos de los mismos.

Info

Publication number
MX2014004860A
MX2014004860A MX2014004860A MX2014004860A MX2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A
Authority
MX
Mexico
Prior art keywords
individual
cancer
biomarker
lung cancer
biomarkers
Prior art date
Application number
MX2014004860A
Other languages
English (en)
Other versions
MX355416B (es
Inventor
Stephen Alaric Williams
Michael Riel-Mehan
Edward N Brody
Alex A E Stewart
Rachel M Ostroff
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of MX2014004860A publication Critical patent/MX2014004860A/es
Publication of MX355416B publication Critical patent/MX355416B/es

Links

Classifications

    • G01N33/5752
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La presente solicitud incluye biomarcadores, métodos, dispositivos, reactivos, sistemas y kits para la detección y diagnóstico de cáncer de pulmón amicrocítico. En otro aspecto, la solicitud proporciona biomarcadores que pueden ser utilizados solos o en diversas combinaciones para diagnosticar cáncer de pulmón amicrocítico o cáncer general. En otro aspecto, se proporcionan métodos para diagnosticar cáncer de pulmón amicrocítico en un individuo, en donde los métodos incluyen detectar, en una muestra biológica de un individuo el valor de por lo menos un biomarcador que corresponde a un biomarcador que se selecciona del grupo de biomarcadores que se proporcionan en la Tabla 1, en donde al individuo se le clasifica que tiene cáncer de pulmón o se determina la probabilidad de que el individuo tenga cáncer de pulmón, en base en el valor de por lo menos un biomarcador. En otro aspecto, se proporcionan métodos para diagnosticar cáncer en un individuo, en donde los métodos incluyen detectar en una muestra biológica de un individuo por lo menos un valor de biomarcador que corresponde por lo menos un biomarcador que se selecciona del grupo de biomarcadores que se proporcionan en la Tabla 19, en donde al individuo se le clasifica que tiene cáncer o se le determina la probabilidad de que el individuo tenga cáncer en base en por lo menos un valor de biomarcador.
MX2014004860A 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos. MX355416B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
MX2014004860A true MX2014004860A (es) 2014-05-27
MX355416B MX355416B (es) 2018-04-18

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004860A MX355416B (es) 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos.

Country Status (15)

Country Link
EP (1) EP2771692B1 (es)
JP (1) JP5986638B2 (es)
KR (1) KR101921945B1 (es)
CN (2) CN106168624B (es)
AU (1) AU2011378427B8 (es)
BR (1) BR112014006432B8 (es)
CA (3) CA2847188C (es)
ES (1) ES2674318T3 (es)
IL (2) IL231426A (es)
IN (1) IN2014CN01787A (es)
MX (1) MX355416B (es)
NZ (1) NZ621733A (es)
SG (1) SG11201400375SA (es)
WO (1) WO2013062515A2 (es)
ZA (1) ZA201401476B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2591357A4 (en) 2010-07-09 2014-01-01 Somalogic Inc Lung cancer biomarkers and uses thereof
AU2013388864B2 (en) * 2013-05-09 2017-06-08 The Procter & Gamble Company Method and system for assessing health condition
CN106715768B (zh) 2014-07-30 2020-06-16 哈佛学院院长及董事 用于测定核酸的系统和方法
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
KR102078310B1 (ko) * 2015-09-11 2020-02-19 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
JP6688884B2 (ja) * 2015-11-05 2020-04-28 ビージーアイ シェンチェン 肺腺癌を検出するためのバイオマーカー及びその使用
IL297634B2 (en) * 2016-03-18 2023-11-01 Caris Science Inc Oligonucleotide probes and their uses
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
CN116732143A (zh) * 2016-11-08 2023-09-12 哈佛学院院长及董事 基质印迹和清除
WO2018158147A1 (en) * 2017-03-01 2018-09-07 Roche Diagnostics Gmbh Systems and methods for classifying a biological sample regarding the presence of an analyte
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
KR20210104076A (ko) 2018-12-13 2021-08-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Merfish 및 다른 적용을 위한 증폭 방법 및 시스템
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
CN113711313A (zh) * 2019-02-15 2021-11-26 佰欧迪塞克斯公司 用于识别手术后处于高复发风险的早期nsclc患者的预测性测试
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
WO2022103843A1 (en) * 2020-11-11 2022-05-19 George Mason Research Foundation, Inc. Laser capture microdissection visualization chemistry
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트
WO2025144995A1 (en) * 2023-12-29 2025-07-03 Novelna Inc. Lung cancer detection proteins and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335170B1 (en) * 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
US6596503B1 (en) 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
US20090297500A1 (en) * 2004-08-10 2009-12-03 Oncotherapy Science, Inc. NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTION WITH RhoA
EP2298895A1 (en) * 2005-07-27 2011-03-23 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
EP1937837A2 (en) * 2005-07-29 2008-07-02 Siemens Healthcare Diagnostics Inc. Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
EP2090665A2 (en) * 2006-10-20 2009-08-19 Exiqon A/S Novel human microRNAs associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
KR101658347B1 (ko) * 2008-09-09 2016-09-21 소마로직, 인크. 폐암 바이오마커 및 그것들의 용도
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CA3153682A1 (en) 2008-11-17 2010-05-20 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
CA2745961A1 (en) * 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer
WO2011100472A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
KR20130056855A (ko) 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들

Also Published As

Publication number Publication date
IN2014CN01787A (es) 2015-05-29
CA2847188C (en) 2020-02-18
AU2011378427A1 (en) 2013-05-16
CA3006793A1 (en) 2013-05-02
BR112014006432B8 (pt) 2022-10-25
AU2011378427B8 (en) 2015-08-27
EP2771692A4 (en) 2015-08-26
IL252163A0 (en) 2017-07-31
CN103890586A (zh) 2014-06-25
JP5986638B2 (ja) 2016-09-06
CN106168624A (zh) 2016-11-30
AU2011378427B2 (en) 2015-07-16
KR20140082840A (ko) 2014-07-02
BR112014006432B1 (pt) 2021-04-06
CN106168624B (zh) 2018-03-13
MX355416B (es) 2018-04-18
BR112014006432A2 (pt) 2017-04-04
ES2674318T3 (es) 2018-06-28
ZA201401476B (en) 2016-06-29
CA3064363A1 (en) 2013-05-02
SG11201400375SA (en) 2014-04-28
WO2013062515A3 (en) 2014-04-17
KR101921945B1 (ko) 2018-11-26
IL231426A (en) 2017-06-29
NZ621733A (en) 2015-05-29
CA2847188A1 (en) 2013-05-02
EP2771692A2 (en) 2014-09-03
IL231426A0 (en) 2014-04-30
WO2013062515A2 (en) 2013-05-02
JP2015501154A (ja) 2015-01-15
CN103890586B (zh) 2016-06-29
EP2771692B1 (en) 2018-04-18
AU2011378427A8 (en) 2015-08-27
CA3064363C (en) 2022-05-17
CA3006793C (en) 2020-02-18

Similar Documents

Publication Publication Date Title
MX2014004860A (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
BR112012032537A2 (pt) biomarcadores de câncer de pulmão e suas utilizações
MX2014003153A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
HK1205764A1 (en) Tuberculosis biomarkers and uses thereof
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
WO2015157704A3 (en) Methods and compositions for detecting misfolded proteins
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
GB2478441A (en) Lung cancer biomarkers and uses thereof
GB2556004A (en) Markers of stroke and stroke severity
MX367366B (es) Composiciones y metodos para diagnosticar tumores de tiroides.
MX368394B (es) Receptor alfa de folato como marcador de diagnostico y pronostico para canceres que expresan receptor alfa de folato.
CA2863637C (en) External files for distribution of molecular diagnostic tests and determination of compatibility between tests
WO2014160275A3 (en) Biomarkers for liver fibrosis
EP4491741A3 (en) Compositions and methods for analyte detection
BR112014015603B1 (pt) métodos para sondagem de múltiplos alvos em uma amostra biológica e para análise da amostra biológica de multiplexação de alta produtividade.
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
WO2016198833A3 (en) Methods for analysing a urine sample
CO6311041A2 (es) Un metodo para determinar y monitorear un cancer ginecologico que comprende la determinacion de niveles de biomarcadores en una muestra biologica
EP4524553A3 (en) Definitive development diagnostic analysis
MX2019002929A (es) Biomarcadores de arn para angioedema hereditario.
WO2015054700A3 (en) Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
HK1221504A1 (zh) 用於前列腺癌的生物标志物检测中的方法和阵列
WO2014160237A3 (en) Methods of prognosing preeclampsia

Legal Events

Date Code Title Description
FG Grant or registration